关于中国在应对TRIPS-plus条款扩张的策略分析 关键词: TRIPS;TRIPS-plus;专利保护;药品可及性 [gap=15144]Key Words: TRIPS; TRIPS-plus; patent protection; access to medicine
基于46个网页-相关网页
专利药品可及性（Drug Access）是指患者以能够承担的价格， 安全、实际地获得适当、高质量的专利药品，并能方便地获得合理使用专利药品的相关 信息。
基于24个网页-相关网页
对于药品专利保护的探讨 关键词：药品可及性；药品专利；健康权 [gap=1003]Key words：drug accessibility; patent; right of health
基于24个网页-相关网页
The second part indicates the rule and the opinion of TRIPS agreement on the access to drugs.
正文第二部分主要分析了TRIPS协议关于药品可及性问题的规定及其评价。
参考来源 - TRIPS协议下发展中国家药品及可及性问题研究In other words it reduces the pharmaceuticals accessibility. As an effective way to solve the problem,compulsory license system becomes the focus of the debate.
专利强制许可制度作为增加药品可及性的有效方式,一直饱受争议。
参考来源 - 新专利法背景下我国药品专利强制许可制度研究In other words it reduces the pharmaceuticals accessibility. As an effective way to solve the problem,compulsory license system becomes the focus of the debate.
专利强制许可制度作为增加药品可及性的有效方式,一直饱受争议。
参考来源 - 新专利法背景下我国药品专利强制许可制度研究·2,447,543篇论文数据，部分数据来源于NoteExpress
然而，据中国药物可及性中国研究小组介绍，降低专利药价格，提高药品可及性，在中国进展并不顺利。
However, according to Chinese medicines for introduction of Chinese research group, lower prices of patented drugs, to improve drug availability in China, progress is not smooth.
如果偏离此种立法精神，消弱专利制度的激励作用，将对药品可及性和不发达国家经济、制药行业产生负面影响。
If we departure this spirit, with the weakness of incentive effect, there would be some negative influences over drug accessibility and economic welfare and Pharmacy Industry.
通过比较研究的方法，对我国药品定价、补偿和可及性等问题提出一些政策建议。
This paper proposes some Suggestions to change policies in drug pricing, reimbursement and access in China by the comparative study.
应用推荐